NCT07725549

Brief Summary

Micronutrient deficiencies during pregnancy may affect the mother's nutritional status and the baby's growth. This study compared two types of daily supplements for pregnant women: a multiple micronutrient supplement and an iron and folic acid supplement. Pregnant women in Indonesia who were at 12 weeks of gestation or earlier were randomly assigned to receive one of the two supplements for eight weeks. The study measured maternal body weight, mid-upper arm circumference, hemoglobin concentration, and serum zinc concentration before and after supplementation. Infant birth weight and the occurrence of low birth weight were assessed after delivery. The purpose of the study was to determine whether multiple micronutrient supplementation produced greater improvements in maternal nutritional indicators and birth outcomes than iron and folic acid supplementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
Last Updated

July 24, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 21, 2026

Last Update Submit

July 21, 2026

Conditions

Keywords

Multiple Micronutrient SupplementationIron and Folic Acid SupplementationMaternal NutritionMaternal HemoglobinBirth WeightLow Birth Weight

Outcome Measures

Primary Outcomes (3)

  • Change in Maternal Body Weight

    Change in maternal body weight calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in kilograms.

    Baseline and 8 weeks

  • Change in Maternal Mid-Upper Arm Circumference

    Change in maternal mid-upper arm circumference calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in centimeters.

    Baseline and 8 weeks

  • Change in Maternal Hemoglobin Concentration

    Change in maternal hemoglobin concentration calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in g/dL. Time Frame:

    Baseline and 8 weeks

Study Arms (2)

Multiple Micronutrient Supplementation

EXPERIMENTAL

Participants assigned to this arm received one multiple micronutrient supplement daily for eight weeks.

Dietary Supplement: Multiple micronutrient supplementation

Iron and Folic Acid Supplementation

ACTIVE COMPARATOR

Participants assigned to this arm received one iron and folic acid supplement daily for eight weeks according to the applicable antenatal supplementation standard.

Dietary Supplement: Iron and Folic Acid Supplementation

Interventions

One tablet was administered orally once daily for eight weeks.

Iron and Folic Acid Supplementation

One tablet was administered orally once daily for eight weeks.

Also known as: MMS
Multiple Micronutrient Supplementation

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women at 12 weeks of gestation or earlier Aged 18 to 40 years No diagnosed chronic disease Willing to complete all study procedures Provided written informed consent

You may not qualify if:

  • Severe pregnancy complications Known allergy to any supplement ingredient Inability to communicate adequately with the research team Planned relocation from the study area within the following six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Puskesmas Grobogan

Purwodadi Grobogan, Central Java, 90222, Indonesia

Location

MeSH Terms

Conditions

Birth Weight

Interventions

Iron

Condition Hierarchy (Ancestors)

Body WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Metals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned in a 1:1 ratio to one of two parallel intervention groups: multiple micronutrient supplementation or iron and folic acid supplementation. Each participant received the assigned supplement daily for eight weeks and remained in the same intervention group throughout the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer and Principal Investigator

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 24, 2026

Study Start

July 10, 2025

Primary Completion

December 25, 2025

Study Completion

April 10, 2026

Last Updated

July 24, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the informed consent obtained from participants did not include permission for sharing individual-level data with external researchers.

Locations